Response: Intensive luteal phase support with oestradiol and progesterone after GnRH agonist triggering: Does it help?

Reproductive BioMedicine Online

Volumn 24, Issue 6, 2012, Pages 682-683

  Humaidan, Peter ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN ANTAGONIST; PROGESTERONE;

EMBRYO TRANSFER; HIGH RISK PATIENT; HORMONAL THERAPY; HUMAN; LETTER; LUTEAL INSUFFICIENCY; LUTEAL PHASE; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; PREGNANCY OUTCOME; UPREGULATION;

EID: 84861813596     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2012.03.006     Document Type: Letter

References (10)

1. R. Babayof, E.J. Margalioth, M. Huleihel, A. Amash, E. Zylber-Haran, M. Gal, B. Brooks, T. Mimoni, and T. Eldar-Geva Serum Inhibin A, VEGF and TNFα levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial Hum. Reprod. 21 2006 1260 1265
2. L. Engmann, A. DiLuigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomised controlled study Fertil. Steril. 89 2008 84 91
3. P. Humaidan Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study Reprod Biomed Online 18 2009 630 634
4. P. Humaidan, L. Bungum, M. Bungum, and C.Y. Andersen Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study Reprod. Biomed. Online. 13 2006 173 178
5. P. Humaidan, H.E. Bredkjaer, L.G. Westergaard, and C.Y. Andersen 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study Fertil. Steril. 93 2010 847 854
6. P. Humaidan, L.G. Westergaard, A.L. Mikkelsen, M. Fukuda, and A.C. Yding Levels of the epidermal growth factor-like peptide amphiregulin in follicular fluid reflect the mode of triggering ovulation: a comparison between gonadotrophin-releasing hormone agonist and urinary human chorionic gonadotrophin Fertil. Steril. 95 2011 2034 2038
7. P. Humaidan, E.G. Papanikolaou, D. Kyrou, B. Alsbjer, N.P. Polyzos, P. Devorey, and H.M. Fatemi The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives Reprod. Biomed. Online. 24 2012 134 141
8. T. Imbar, S. Kol, F. Lossos, Y. Bdolah, A. Hurwitz, and R. Haimov-Kochman Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support Hum. Reprod. 27 2012 753 759
9. R. Orvieto, J. Rabinson, S. Meltzer, E. Zohav, E. Anteby, and R. Homburg Substituting HCG with GnRH agonist to trigger final follicular maturation - a retrospective comparison of three different stimulation protocols Reprod. Biomed. Online. 13 2006 198 201
10. B. Radesic, and K. Tremellen Oocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates Hum. Reprod. 26 2011 3437 3442